2026-11-14

#reports #SRG

[Seritage Growth Properties](https://eninvs.com/all.php?name=SRG) (REIT — Retail) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204414)
(2026-05-15, After Market Close):

- Revenue -33.3% YoY (vs -50.0% in previous quarter and historical rate -34.7%)
- EBITDA margin -200.0% increased compared to -366.7% same period last year
- Net Debt increased by $15 mln over the past reporting period (17.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.3% of market cap
- EV/Sales multiple is 10.4x

------------------------------------------------

2026-11-14

#reports #SGRP

[SPAR Group](https://eninvs.com/all.php?name=SGRP) (Specialty Business Services) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204389)
(2026-05-12, Before Market Open):

- Revenue -20.9% YoY (vs -2.6% in previous quarter and historical rate -18.2%)
- P/S multiple is 0.1x
- Price to book: 0.7x

------------------------------------------------

2026-11-14

#reports #RHE

[Regional Health Properties](https://eninvs.com/all.php?name=RHE) (Medical Care Facilities) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204388)
(2025-04-03):

- Revenue +66.7% YoY (vs +140.0% in previous quarter and historical rate +81.8%)
- EBITDA -80% YoY (vs -100.0% in previous quarter)
- EBITDA margin 4.0% decreased compared to 33.3% same period last year
- Net Debt decreased by $1 mln over the past reporting period (20377.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2669447.3% of market cap
- EV/EBITDA multiple is 21.5x compared to historical level (75th percentile) of 17.5x
- EV/Sales multiple is 1.4x

------------------------------------------------

2026-11-14

#reports #OPRX

[OptimizeRx Corporation](https://eninvs.com/all.php?name=OPRX) (Health Information Services) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204408)
(2026-05-12, After Market Close):

- Revenue +10% YoY (vs -25.0% in previous quarter and historical rate +11.6%)
- EBITDA margin 18.2% increased compared to -20.0% same period last year
- Net Debt decreased by $4 mln over the past reporting period (2.9% of market cap)
- EV/Sales multiple is 1.6x

------------------------------------------------

2026-11-14

#reports #NVFY

[Nova LifeStyle](https://eninvs.com/all.php?name=NVFY) (Furnishings, Fixtures and Appliances) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204409)
(2025-08-14):

- Revenue +200% YoY (vs 0.0% in previous quarter and historical rate +9.0%)
- EBITDA margin -16.7% increased compared to -50.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (11.8% of market cap)
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-11-14

#reports #NKTR

[Nektar Therapeutics](https://eninvs.com/all.php?name=NKTR) (Medicines developer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204454)
(2026-03-12, After Market Close):

- Revenue -25% YoY (vs -9.1% in previous quarter and historical rate -13.3%)
- EBITDA margin -644.4% decreased compared to -266.7% same period last year
- Net Debt increased by $66 mln over the past reporting period (5.2% of market cap)
- FCF (LTM) +$0.4 bln (positive), 33.6% of market cap
- EV/Sales multiple is 14.1x

------------------------------------------------

2026-11-14

#reports #MITQ

[Moving iMage Technologies, Inc.](https://eninvs.com/all.php?name=MITQ) (Communication Equipment) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204424)
(2026-05-14, Before Market Open):

- Revenue 0% YoY (vs -16.7% in previous quarter and historical rate -4.7%)
- Net Debt decreased by $3 mln over the past reporting period (53.3% of market cap)
- FCF (LTM) +$0 bln (positive), 17.8% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 5x
- EV/Sales multiple is 0x

------------------------------------------------

2026-11-14

#reports #HCTI

[Healthcare Triangle, Inc.](https://eninvs.com/all.php?name=HCTI) (Health Information Services) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204429)
(2025-11-13):

- Revenue +200% YoY (vs +125.0% in previous quarter and historical rate +24.9%)
- EBITDA margin -22.2% increased compared to -100.0% same period last year
- Net Debt decreased by $18 mln over the past reporting period (209.9% of market cap)
- FCF (LTM) -$0 bln (negative), 46.6% of market cap
- EV/Sales multiple is 0.4x

------------------------------------------------

2026-11-14

#reports #FTHM

[Fathom](https://eninvs.com/all.php?name=FTHM) (Real Estate Services) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204423)
(2026-05-29, After Market Close):

- Revenue -4.3% YoY (vs -1.1% in previous quarter and historical rate +11.5%)
- EBITDA margin -18.0% decreased compared to -3.2% same period last year
- Net Debt decreased by $3 mln over the past reporting period (103.6% of market cap)
- FCF (LTM) -$0 bln (negative), 276.3% of market cap
- EV/Sales multiple is 0x

------------------------------------------------

2026-11-14

#reports #FBIOP

[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204407)
(2026-03-31):

- Revenue +46.2% YoY (vs +6.7% in previous quarter and historical rate +9.5%)
- EBITDA -158.3% YoY (vs -600.0% in previous quarter and historical rate +26.6%)
- EBITDA margin -36.8% decreased compared to 92.3% same period last year
- Net Debt decreased by $96 mln over the past reporting period (19.6% of market cap)
- FCF (LTM) -$0 bln (negative), 2.0% of market cap
- EV/Sales multiple is 5.7x

------------------------------------------------

2026-11-14

#reports #BYFC

[Broadway Financial Corporation](https://eninvs.com/all.php?name=BYFC) (Banks — Regional) reported for [2026 q3](https://eninvs.com/press_release.php?ticker=BYFC&q=2026 q3&id=983104)
(2026-11-13, After Market Close):

- Revenue +25% YoY (vs -47.1% in previous quarter and historical rate +15.8%)
- Net Income margin 10.0% decreased compared to 12.5% same period last year
- P/S multiple is 2.9x
- Price to book: 0.4x

------------------------------------------------

2026-11-14

#reports #BFRI

[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204435)
(2026-03-19, Before Market Open):

- Revenue 0% YoY (vs +33.3% in previous quarter and historical rate +26.6%)
- EBITDA margin -66.7% decreased compared to -55.6% same period last year
- Net Debt increased by $5 mln over the past reporting period (39.8% of market cap)
- FCF (LTM) -$0 bln (negative), 47.7% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-11-14

#reports #AIRI

[Air Industries Group](https://eninvs.com/all.php?name=AIRI) (Aerospace and Defense) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204390)
(2026-03-27, After Market Close):

- Revenue +103835.7% YoY (vs +92169.2% in previous quarter and historical rate +48.4%)
- EBITDA margin 8.9% increased compared to 0.0% same period last year
- Net Debt increased by $191 mln over the past reporting period (1568.1% of market cap)
- FCF (LTM) -$0 bln (negative), 8.2% of market cap
- EV/EBITDA multiple is 16.7x compared to historical level (75th percentile) of 16.5x
- EV/Sales multiple is 0.8x

------------------------------------------------

2026-11-14

#reports #FBIO

[Fortress Biotech](https://eninvs.com/all.php?name=FBIO) (Biotechnology) reported for 2026 q3
(2026-03-31, After Market Close):

- Revenue +5.6% YoY (vs +18.8% in previous quarter and historical rate +1.7%)
- EBITDA margin -31.6% increased compared to -33.3% same period last year
- EV/Sales multiple is 0.7x

------------------------------------------------

2026-11-13

#reports #TAL
@ china , @ edtech

[TAL Education](https://eninvs.com/all.php?name=TAL) (Educational service provider) reported for 2026 q3
(2026-04-23, Before Market Open):

- Revenue -7.1% YoY (vs -9.0% in previous quarter and historical rate -6.0%)
- EBITDA -72.2% YoY (vs -52.4% in previous quarter)
- EBITDA margin 7.7% decreased compared to 25.7% same period last year
- Net Debt decreased by $13 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 89.1x compared to historical level (75th percentile) of 646x
- EV/Sales multiple is 24.6x

------------------------------------------------

2026-11-13

#reports #YETI

[YETI](https://eninvs.com/all.php?name=YETI) (Goods for outdoor activities manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204311)
(2026-05-14, Before Market Open):

- Revenue +4.3% YoY (vs +8.5% in previous quarter and historical rate +8.4%)
- EBITDA +11.8% YoY (vs +44.0% in previous quarter and historical rate +32.4%)
- EBITDA margin 14.9% increased compared to 13.9% same period last year
- Net Debt decreased by $43 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-11-13

#reports #XBIO

[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204302)
(2026-03-12, Before Market Open):

- Revenue -29.4% YoY (vs +12.0% in previous quarter and historical rate +11.0%)
- EBITDA margin -238.6% decreased compared to -52.2% same period last year
- Net Debt increased by $662 mln over the past reporting period (17019.4% of market cap)
- FCF (LTM) +$2.4 bln (positive), 60416.3% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is -2x

------------------------------------------------

2026-11-13

#reports #WWW

[Wolverine World Wide](https://eninvs.com/all.php?name=WWW) (Clothing/shoes/accessories manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204269)
(2026-05-14, Before Market Open):

- Revenue +7.4% YoY (vs +6.8% in previous quarter and historical rate -4.4%)
- EBITDA +76.7% YoY (vs +9.4% in previous quarter and historical rate +38.9%)
- EBITDA margin 21.0% increased compared to 12.8% same period last year
- Net Debt decreased by $50 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 8.0% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-11-13

#reports #VRME

[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for 2026 q3
(2026-05-15, Before Market Open):

- Revenue +40% YoY (vs -60.0% in previous quarter and historical rate -18.0%)
- EBITDA margin -128.6% decreased compared to 0.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0 bln (positive), 2.0% of market cap
- EV/Sales multiple is 7.4x

------------------------------------------------

2026-11-13

#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204382)
(2026-05-15, After Market Close):

- Revenue +157.4% YoY (vs -2.0% in previous quarter and historical rate +77.8%)
- EBITDA margin -195.5% increased compared to -774.0% same period last year
- Net Debt decreased by $3.1 bln since the start of the year (15879.8% of market cap)
- FCF (LTM) +$3.6 bln (positive), 18066.5% of market cap
- EV/Sales multiple is 1.8x

------------------------------------------------

2026-11-13

#reports #TWST

[Twist Bioscience](https://eninvs.com/all.php?name=TWST) (Medical services provider) reported for 2026 q3
(2026-05-04, Before Market Open):

- Revenue +28.3% YoY (vs +22.9% in previous quarter and historical rate +23.5%)
- EBITDA margin -16.5% increased compared to -27.3% same period last year
- Net Debt decreased by $414 mln over the past reporting period (5.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.2% of market cap
- EV/Sales multiple is 14.5x

------------------------------------------------

2026-11-13

#reports #TTEK

[Tetra Tech](https://eninvs.com/all.php?name=TTEK) (Consulting company) reported for 2026 q3
(2026-01-28, After Market Close):

- Revenue +0.5% YoY (vs -4.5% in previous quarter and historical rate +4.9%)
- EBITDA +10.2% YoY (vs -3.4% in previous quarter and historical rate +38.2%)
- EBITDA margin 16.2% increased compared to 14.7% same period last year
- Net Debt increased by $78 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.8% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 21.4x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +7.7%

------------------------------------------------

2026-11-13

#reports #TACT

[TransAct Technologies](https://eninvs.com/all.php?name=TACT) (Computer Hardware) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue +7.7% YoY (vs 0.0% in previous quarter and historical rate -8.1%)
- Net Debt decreased by $1 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 2.0% of market cap
- EV/EBITDA multiple is 33.4x compared to historical level (75th percentile) of 32x
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-11-13

#reports #SSTI

[ShotSpotter](https://eninvs.com/all.php?name=SSTI) (Software — Application) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204283)
(2026-05-14, After Market Close):

- Revenue 0% YoY (vs -7.7% in previous quarter and historical rate -3.2%)
- EBITDA margin -28.0% decreased compared to -8.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0 bln (negative), 4.6% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-11-13

#reports #SRTS

[Sensus Healthcare](https://eninvs.com/all.php?name=SRTS) (Medical Devices) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue -14.3% YoY (vs -71.4% in previous quarter and historical rate +10.3%)
- EBITDA margin -16.7% increased compared to -28.6% same period last year
- EV/Sales multiple is 2.2x

------------------------------------------------

2026-11-13

#reports #SPB

[Spectrum Brands](https://eninvs.com/all.php?name=SPB) (Consumer goods manufacturer) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue -7.9% YoY (vs -3.3% in previous quarter and historical rate +4.9%)
- EBITDA -51% YoY (vs -80.7% in previous quarter and historical rate +2.9%)
- EBITDA margin 3.4% decreased compared to 6.3% same period last year
- Net Debt decreased by $69 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 22.7x compared to historical level (75th percentile) of 20.9x
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-13

#reports #SMSI

[Smith Micro Software](https://eninvs.com/all.php?name=SMSI) (Software — Application) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204386)
(2026-03-04, After Market Close):

- Revenue +25% YoY (vs 0.0% in previous quarter and historical rate -23.7%)
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-13

#reports #RKDA

[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204292)
(2026-03-26, After Market Close):

- Revenue +100% YoY (vs 0.0% in previous quarter and historical rate 0.0%)
- EBITDA margin -50.0% increased compared to -100.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (74.3% of market cap)
- FCF (LTM) -$0 bln (negative), 148.5% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 1x
- EV/Sales multiple is -0.3x

------------------------------------------------

2026-11-13

#reports #OPHC

[OptimumBank](https://eninvs.com/all.php?name=OPHC) (Banks — Regional) reported for 2026 q3
(2026-02-02, Before Market Open):

- Revenue +13.3% YoY (vs -6.3% in previous quarter and historical rate +67.4%)
- Net Income margin 52.9% increased compared to 0.0% same period last year
- P/E multiple is 8.3x compared to historical level (75th percentile) of 3.8x
- P/S multiple is 3.8x
- Price to book: 1.8x

At the opening of the session the share price went down -1.0%

------------------------------------------------

2026-11-13

#reports #NUWE

[Nuwellis](https://eninvs.com/all.php?name=NUWE) (Medical Devices) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204297)
(2026-03-11):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -100.0% increased compared to -150.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (220.5% of market cap)
- FCF (LTM) -$0 bln (negative), 220.5% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-11-13

#reports #NSPR

[InspireMD](https://eninvs.com/all.php?name=NSPR) (Medical Devices) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue -33.3% YoY (vs 0.0% in previous quarter and historical rate +26.4%)
- EBITDA margin -500.0% decreased compared to -433.3% same period last year
- Net Debt decreased by $35 mln over the past reporting period (97.3% of market cap)
- FCF (LTM) -$0 bln (negative), 136.2% of market cap
- EV/EBITDA multiple is 0.5x compared to historical level (75th percentile) of 1x
- EV/Sales multiple is -2.7x

------------------------------------------------

2026-11-13

#reports #MGTX

[MeiraGTx](https://eninvs.com/all.php?name=MGTX) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204326)
(2026-05-14, Before Market Open):

- Revenue -64.3% YoY (vs +120.0% in previous quarter and historical rate +6.2%)
- EBITDA margin -940.0% decreased compared to -407.1% same period last year
- Net Debt decreased by $15 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/Sales multiple is 47.1x

------------------------------------------------

2026-11-13

#reports #INVE

[Identiv](https://eninvs.com/all.php?name=INVE) (Computer Hardware) reported for 2026 q3
(2026-05-13, After Market Close):

- Revenue -40% YoY (vs +20.0% in previous quarter and historical rate -31.2%)
- EBITDA margin -266.7% decreased compared to -100.0% same period last year
- Net Debt increased by $32 mln over the past reporting period (49.5% of market cap)
- FCF (LTM) -$0 bln (negative), 9.3% of market cap
- EV/EBITDA multiple is 1.1x compared to historical level (75th percentile) of 2.9x
- EV/Sales multiple is -1x

------------------------------------------------

2026-11-13

#reports #INTZ

[Intrusion](https://eninvs.com/all.php?name=INTZ) (Software — Infrastructure) reported for 2026 q3
(2026-03-24, After Market Close):

- Revenue +50% YoY (vs -50.0% in previous quarter and historical rate +25.0%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- EV/Sales multiple is 3.2x

------------------------------------------------

2026-11-13

#reports #IDN

[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204264)
(2026-05-12, After Market Close):

- Revenue 0% YoY (vs +20.0% in previous quarter and historical rate +24.9%)
- Net Debt decreased by $2 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0 bln (positive), 8.8% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 112x
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-13

#reports #ICCC

[ImmuCell Corporation](https://eninvs.com/all.php?name=ICCC) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204366)
(2026-05-14, After Market Close):

- Revenue +33.7% YoY (vs +143620.0% in previous quarter and historical rate +78.9%)
- EBITDA margin 17.6% increased compared to -9.6% same period last year
- Net Debt increased by $509 mln over the past reporting period (548.2% of market cap)
- FCF (LTM) +$5.8 bln (positive), 6248.2% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 138.8x
- EV/Sales multiple is 0.1x

------------------------------------------------

2026-11-13

#reports #HSON

[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for 2026 q3
(2025-08-08, Before Market Open):

- Revenue +12.5% YoY (vs +52.8% in previous quarter and historical rate +19.3%)
- EBITDA margin -1.9% increased compared to -2.1% same period last year
- Net Debt decreased by $1 mln over the past reporting period (22.1% of market cap)
- FCF (LTM) +$0 bln (positive), 332.1% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 9.3x
- EV/Sales multiple is -0x

At the opening of the session the share price went up +3.1%

------------------------------------------------

2026-11-13

#reports #HQI

[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue +12.5% YoY (vs 0.0% in previous quarter and historical rate -4.1%)
- EBITDA 0% YoY (vs +100.0% in previous quarter and historical rate -5.9%)
- EBITDA margin 33.3% decreased compared to 37.5% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 23.1x compared to historical level (75th percentile) of 23.6x
- EV/Sales multiple is 8.2x

------------------------------------------------

2026-11-13

#reports #GTEC

[Greenland Technologies Corporation](https://eninvs.com/all.php?name=GTEC) (Specialty Industrial Machinery) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204325)
(2026-05-29, Before Market Open):

- Revenue +13.6% YoY (vs +57.9% in previous quarter and historical rate +7.4%)
- EBITDA +80% YoY (vs +50.0% in previous quarter and historical rate +38.4%)
- EBITDA margin 36.0% increased compared to 22.7% same period last year
- Net Debt decreased by $6 mln over the past reporting period (45.7% of market cap)
- FCF (LTM) -$0 bln (negative), 274.3% of market cap
- EV/Sales multiple is -0.3x

------------------------------------------------

2026-11-13

#reports #GROW

[U.S. Global Investors](https://eninvs.com/all.php?name=GROW) (Asset Management) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204361)
(2026-02-20, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -21.9%)
- P/E multiple is 15.5x compared to historical level (75th percentile) of 38x
- P/S multiple is 2.6x
- Price to book: 0.7x

------------------------------------------------

2026-11-13

#reports #EYPT

[EyePoint Pharmaceuticals](https://eninvs.com/all.php?name=EYPT) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204281)
(2026-05-06, Before Market Open):

- Revenue -80% YoY (vs -95.8% in previous quarter and historical rate -18.0%)
- EBITDA margin -9400.0% decreased compared to -1240.0% same period last year
- Net Debt increased by $62 mln over the past reporting period (170.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 365.9% of market cap
- EV/EBITDA multiple is 0.2x compared to historical level (75th percentile) of 0.4x
- EV/Sales multiple is -15.7x

------------------------------------------------

2026-11-13

#reports #EYE

[National Vision](https://eninvs.com/all.php?name=EYE) (Optics supplier) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204321)
(2026-05-13, Before Market Open):

- Revenue +4.9% YoY (vs +2.7% in previous quarter and historical rate 0.0%)
- EBITDA +223.5% YoY (vs +10.4% in previous quarter)
- EBITDA margin 21.5% increased compared to 7.0% same period last year
- Net Debt decreased by $29 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 23.4x
- EV/Sales multiple is 1x

------------------------------------------------

2026-11-13

#reports #EPC

[Edgewell Personal Care Company](https://eninvs.com/all.php?name=EPC) (Personal care products manufacturer) reported for 2026 q3
(2026-05-06, Before Market Open):

- Revenue -33.8% YoY (vs +1.8% in previous quarter and historical rate -2.5%)
- EBITDA +111.8% YoY (vs -34.3% in previous quarter and historical rate -21.2%)
- EBITDA margin 7.4% increased compared to 2.3% same period last year
- Net Debt increased by $61 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 26.2% of market cap
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 11.8x
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-11-13

#reports #DXYN

[The Dixie Group](https://eninvs.com/all.php?name=DXYN) (Textile Manufacturing) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204247)
(2026-03-26, Before Market Open):

- Revenue +4.8% YoY (vs 0.0% in previous quarter and historical rate -3.0%)
- EBITDA margin 4.6% increased compared to -1.6% same period last year
- Net Debt decreased by $4 mln over the past reporting period (60.1% of market cap)
- FCF (LTM) -$0 bln (negative), 30.1% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 22x
- EV/Sales multiple is 0.4x

------------------------------------------------

2026-11-13

#reports #DTC

[Solo Brands, Inc.](https://eninvs.com/all.php?name=DTC) (Internet Retail) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204349)
(2025-05-12, Before Market Open):

- Revenue -53.2% YoY (vs -33.3% in previous quarter and historical rate -13.8%)
- EBITDA margin -4.5% increased compared to -114.9% same period last year
- Net Debt increased by $12 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 2.7% of market cap
- EV/Sales multiple is 5.1x

At the opening of the session the share price went down -14.8%

------------------------------------------------

2026-11-13

#reports #DRIO

[DarioHealth](https://eninvs.com/all.php?name=DRIO) (Diagnostics and Research) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204301)
(2026-03-19, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +3.1%)
- EBITDA -20% YoY (vs -22.2% in previous quarter and historical rate -10.8%)
- EBITDA margin 160.0% decreased compared to 200.0% same period last year
- EV/EBITDA multiple is 1.6x compared to historical level (75th percentile) of 15.8x
- EV/Sales multiple is 2.4x

------------------------------------------------

2026-11-13

#reports #DGII

[Digi International](https://eninvs.com/all.php?name=DGII) (Communication Equipment) reported for 2026 q3
(2026-05-06, After Market Close):

- Revenue +25.4% YoY (vs +28.7% in previous quarter and historical rate +7.1%)
- EBITDA +66.7% YoY (vs +32.0% in previous quarter and historical rate +31.6%)
- EBITDA margin 14.0% increased compared to 10.5% same period last year
- Net Debt decreased by $42 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 22.3x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 4.2x

------------------------------------------------

2026-11-13

#reports #DERM

[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204348)
(2026-05-13, After Market Close):

- Revenue +26.7% YoY (vs +38.5% in previous quarter and historical rate +11.5%)
- EBITDA margin -5.3% increased compared to -20.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) +$0 bln (positive), 2.4% of market cap
- EV/Sales multiple is 1.8x

------------------------------------------------

2026-11-13

#reports #DDI

[DoubleDown Interactive Co., Ltd.](https://eninvs.com/all.php?name=DDI) (Electronic Gaming and Multimedia) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue -2.1% YoY (vs +10.6% in previous quarter and historical rate +8.1%)
- EBITDA +8.1% YoY (vs +12.1% in previous quarter and historical rate +24.3%)
- EBITDA margin 42.6% increased compared to 38.5% same period last year
- Net Debt decreased by $24 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 15.2% of market cap
- EV/EBITDA multiple is 1.7x compared to historical level (75th percentile) of 2.8x
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-11-13

#reports #DAIO

[Data I/O Corporation](https://eninvs.com/all.php?name=DAIO) (Electronic Components) reported for 2026 q3
(2026-07-23, After Market Close):

- Revenue 0% YoY (vs -16.7% in previous quarter and historical rate -13.9%)
- EBITDA margin -40.0% decreased compared to -20.0% same period last year
- Net Debt increased by $8 mln over the past reporting period (29.1% of market cap)
- FCF (LTM) +$0 bln (positive), 7.3% of market cap
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-11-13

#reports #CRWS

[Crown Crafts](https://eninvs.com/all.php?name=CRWS) (Furnishings, Fixtures and Appliances) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204354)
(2026-06-24, Before Market Open):

- Revenue -20.8% YoY (vs 0.0% in previous quarter and historical rate +0.1%)
- EBITDA -50% YoY (vs -25.0% in previous quarter and historical rate +11.8%)
- EBITDA margin 10.5% decreased compared to 16.7% same period last year
- Net Debt decreased by $19 mln over the past reporting period (72.3% of market cap)
- FCF (LTM) -$0 bln (negative), 15.2% of market cap
- EV/EBITDA multiple is 4.5x compared to historical level (75th percentile) of 6.9x
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-11-13

#reports #BKTI

[BK Technologies Corporation](https://eninvs.com/all.php?name=BKTI) (Communication Equipment) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204353)
(2026-03-12, Before Market Open):

- Revenue +4.2% YoY (vs +9.5% in previous quarter and historical rate +5.8%)
- EBITDA 0% YoY (vs +25.0% in previous quarter and historical rate +116.0%)
- EBITDA margin 20.0% decreased compared to 20.8% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0 bln (positive), 3.2% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 86.1x
- EV/Sales multiple is 2.5x

------------------------------------------------

2026-11-13

#reports #AVAH

[Aveanna Healthcare Holdings Inc.](https://eninvs.com/all.php?name=AVAH) (Medical Care Facilities) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204338)
(2026-05-14, Before Market Open):

- Revenue +36.7% YoY (vs +32.7% in previous quarter and historical rate +31.9%)
- EBITDA +357.9% YoY (vs +62.7% in previous quarter and historical rate +97.8%)
- EBITDA margin 12.5% increased compared to 3.7% same period last year
- Net Debt decreased by $102 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.5% of market cap
- EV/EBITDA multiple is 8x compared to historical level (75th percentile) of 15.6x
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-13

#reports #TISI

[Team](https://eninvs.com/all.php?name=TISI) (Specialty Business Services) reported for 2026 q3
(2026-03-12, After Market Close):

- Revenue -2.2% YoY (vs -7.7% in previous quarter and historical rate +1.3%)
- Net Income margin -5.0% decreased compared to -4.9% same period last year
- P/E multiple is 6.7x compared to historical level (75th percentile) of 59x
- P/S multiple is 0.1x
- Price to book: 3.3x

------------------------------------------------

2026-11-13

#reports #STRO

[Sutro Biopharma](https://eninvs.com/all.php?name=STRO) (Biotechnology) reported for 2026 q3
(2026-05-14, After Market Close):

- Revenue 0% YoY (vs -61.5% in previous quarter and historical rate +18.8%)
- EBITDA margin -233.3% increased compared to -433.3% same period last year
- Net Debt increased by $154 mln over the past reporting period (96.7% of market cap)
- FCF (LTM) -$0 bln (negative), 22.0% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2026-11-13

#reports #SKYX

[SKYX Platforms Corp.](https://eninvs.com/all.php?name=SKYX) (Consumer Electronics) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue +8.3% YoY (vs +8.7% in previous quarter and historical rate +40.5%)
- EBITDA margin -19.2% increased compared to -20.8% same period last year
- Net Debt decreased by $23.1 bln since the start of the year (20945.5% of market cap)
- FCF (LTM) +$20.6 bln (positive), 18620.2% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-11-13

#reports #REKR

[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue -21.4% YoY (vs +8.3% in previous quarter and historical rate +23.0%)
- EBITDA margin -18.2% increased compared to -21.4% same period last year
- Net Debt increased by $5 mln over the past reporting period (11.4% of market cap)
- FCF (LTM) +$0 bln (positive), 4.5% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-11-13

#reports #RCMT

[RCM Technologies](https://eninvs.com/all.php?name=RCMT) (Engineering and Construction) reported for 2026 q3
(2026-05-29, After Market Close):

- Revenue +4.3% YoY (vs +20.5% in previous quarter and historical rate +9.2%)
- EBITDA +25% YoY (vs +28.6% in previous quarter and historical rate +10.4%)
- EBITDA margin 6.8% increased compared to 5.7% same period last year
- Net Debt decreased by $23 mln over the past reporting period (10.3% of market cap)
- FCF (LTM) +$0 bln (positive), 8.5% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 12.2x
- EV/Sales multiple is 0.7x

------------------------------------------------

2026-11-13

#reports #RAMP

[LiveRamp](https://eninvs.com/all.php?name=RAMP) (Software provider) reported for 2026 q3
(2026-05-18, After Market Close):

- Revenue +7.5% YoY (vs +9.7% in previous quarter and historical rate +11.7%)
- EBITDA +8% YoY (vs +109.1% in previous quarter and historical rate +94.1%)
- EBITDA margin 12.6% has not changed compared to 12.5% same period last year
- Net Debt increased by $371 mln over the past reporting period (3378.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1602.6% of market cap
- EV/Sales multiple is -0.4x

------------------------------------------------

2026-11-13

#reports #NPCE

[NeuroPace, Inc.](https://eninvs.com/all.php?name=NPCE) (Medical Devices) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue 0% YoY (vs +15.0% in previous quarter and historical rate +26.0%)
- EBITDA margin -8.7% increased compared to -17.4% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.4% of market cap
- EV/Sales multiple is 4.1x

------------------------------------------------

2026-11-13

#reports #MGNX

[MacroGenics](https://eninvs.com/all.php?name=MGNX) (Biotechnology) reported for 2026 q3
(2026-05-13, After Market Close):

- Revenue -64.2% YoY (vs -77.7% in previous quarter and historical rate +24.0%)
- EBITDA -266.7% YoY (vs -1400.0% in previous quarter and historical rate +20.4%)
- EBITDA margin -105.3% decreased compared to 22.6% same period last year
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-13

#reports #LWAY

[Lifeway Foods](https://eninvs.com/all.php?name=LWAY) (Packaged Foods) reported for 2026 q3
(2026-05-14, Before Market Open):

- Revenue +19.3% YoY (vs +24.1% in previous quarter and historical rate +18.2%)
- EBITDA -66.7% YoY (vs -71.4% in previous quarter and historical rate +25.2%)
- EBITDA margin 2.9% decreased compared to 10.5% same period last year
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 19.1x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-11-13

#reports #LVLU

[Lulu's Fashion Lounge Holdings, Inc.](https://eninvs.com/all.php?name=LVLU) (Apparel Retail) reported for 2026 q3
(2026-03-30, After Market Close):

- Revenue -20.3% YoY (vs -17.1% in previous quarter and historical rate -12.4%)
- EBITDA margin -5.1% decreased compared to -1.4% same period last year
- EV/Sales multiple is 0.2x

------------------------------------------------

2026-11-13

#reports #ENS

[EnerSys](https://eninvs.com/all.php?name=ENS) (Industrial battery manufacturer) reported for 2026 q3
(2026-05-20, After Market Close):

- Revenue -0.1% YoY (vs +4.8% in previous quarter and historical rate +0.8%)
- EBITDA +20% YoY (vs +61.1% in previous quarter and historical rate +14.2%)
- EBITDA margin 15.2% increased compared to 12.6% same period last year
- Net Debt increased by $31 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.7 bln (positive), 12.9% of market cap
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-11-13

#reports #CTVA

[Corteva](https://eninvs.com/all.php?name=CTVA) ( Agricultural products provider ) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue -6.1% YoY (vs -1.2% in previous quarter and historical rate +0.5%)
- EBITDA margin -11.5% decreased compared to -2.7% same period last year
- Net Debt decreased by $3 bln since the start of the year (7.3% of market cap)
- FCF (LTM) -$8.5 bln (negative), 20.8% of market cap
- EV/EBITDA multiple is 15.6x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 2.3x

------------------------------------------------

2026-11-13

#reports #CDXS

[Codexis](https://eninvs.com/all.php?name=CDXS) (Biotechnology) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +111.1% YoY (vs 0.0% in previous quarter and historical rate +22.4%)
- EBITDA margin -31.6% increased compared to -200.0% same period last year
- Net Debt decreased by $18 mln over the past reporting period (28.8% of market cap)
- FCF (LTM) -$0 bln (negative), 25.6% of market cap
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-13

#reports #ARTNA

[Artesian Resources Corporation](https://eninvs.com/all.php?name=ARTNA) (Utilities — Regulated Water) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue +6.7% YoY (vs +6.9% in previous quarter and historical rate +6.4%)
- EBITDA 0% YoY (vs +9.1% in previous quarter and historical rate +8.4%)
- EBITDA margin 37.5% decreased compared to 40.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 5.1% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 4.3x

------------------------------------------------

2026-11-11

#reports #XGN

[Exagen](https://eninvs.com/all.php?name=XGN) (Diagnostics and Research) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204197)
(2026-05-11, Before Market Open):

- Revenue +5.9% YoY (vs +13.3% in previous quarter and historical rate +10.1%)
- EBITDA margin -16.7% decreased compared to -11.8% same period last year
- Net Debt decreased by $3 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0 bln (negative), 5.1% of market cap
- EV/Sales multiple is 2x

------------------------------------------------

2026-11-11

#reports #UONEK

[Urban One](https://eninvs.com/all.php?name=UONEK) (Broadcasting) reported for 2026 q3
(2026-03-12, Before Market Open):

- Revenue -15.4% YoY (vs -35.0% in previous quarter and historical rate -4.7%)
- EBITDA -500% YoY (vs -87.9% in previous quarter and historical rate -11.7%)
- EBITDA margin -136.4% decreased compared to 28.8% same period last year
- Net Debt increased by $16 mln over the past reporting period (104.7% of market cap)
- FCF (LTM) +$0 bln (positive), 91.6% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-11-11

#reports #SONO

[Sonos](https://eninvs.com/all.php?name=SONO) (Audio manufacturer) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +19.4% YoY (vs +8.7% in previous quarter and historical rate +5.2%)
- Net Debt increased by $36 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 62.4x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-11-11

#reports #SND

[Smart Sand](https://eninvs.com/all.php?name=SND) (Oil and Gas Equipment and Services) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204217)
(2026-05-12, After Market Close):

- Revenue +30.2% YoY (vs +74.2% in previous quarter and historical rate +13.5%)
- EBITDA +42.9% YoY (vs +1000.0% in previous quarter)
- EBITDA margin 8.9% increased compared to 8.1% same period last year
- Net Debt decreased by $11 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 31.5% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 40.4x
- EV/Sales multiple is 0.4x

------------------------------------------------

2026-11-11

#reports #SLAB

[Silicon Laboratories](https://eninvs.com/all.php?name=SLAB) (Semiconductor manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204187)
(2026-05-05, After Market Close):

- Revenue +73.1% YoY (vs +115.1% in previous quarter and historical rate +15.6%)
- EBITDA margin 5.6% increased compared to -22.8% same period last year
- Net Debt decreased by $43 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.8% of market cap
- EV/Sales multiple is 8.1x

------------------------------------------------

2026-11-11

#reports #REZI

[Resideo Technologies](https://eninvs.com/all.php?name=REZI) (Smart home device manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204229)
(2026-05-12, After Market Close):

- Revenue -61% YoY (vs +2.0% in previous quarter and historical rate +44.4%)
- EBITDA -54.2% YoY (vs -19.9% in previous quarter and historical rate +18.7%)
- EBITDA margin 12.8% increased compared to 10.9% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (44.9% of market cap)
- FCF (LTM) +$1.2 bln (positive), 39.2% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 9.6x
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-11-11

#reports #QUIK

[QuickLogic Corporation](https://eninvs.com/all.php?name=QUIK) (Semiconductors) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue +150% YoY (vs +25.0% in previous quarter and historical rate +15.4%)
- EBITDA margin -20.0% increased compared to -150.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 6.5% of market cap
- EV/Sales multiple is 7.5x

------------------------------------------------

2026-11-11

#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204189)
(2026-03-30, After Market Close):

- Revenue 0% YoY (vs +16.7% in previous quarter and historical rate +25.6%)
- Net Debt decreased by $1 mln over the past reporting period (2.4% of market cap)
- EV/EBITDA multiple is 43.4x compared to historical level (75th percentile) of 610x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-11-11

#reports #PETS

[PetMed Express](https://eninvs.com/all.php?name=PETS) (Pet supplies seller) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204188)
(2026-06-02, After Market Close):

- Revenue -32.1% YoY (vs -26.7% in previous quarter and historical rate -10.8%)
- EBITDA margin -11.1% decreased compared to 1.9% same period last year
- Net Debt increased by $24 mln over the past reporting period (90.4% of market cap)
- FCF (LTM) -$0 bln (negative), 52.7% of market cap
- EV/Sales multiple is 0.1x

------------------------------------------------

2026-11-11

#reports #MRCY

[Mercury Systems](https://eninvs.com/all.php?name=MRCY) (Aerospace and Defense) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue +12.4% YoY (vs +6.2% in previous quarter and historical rate +10.7%)
- EBITDA +350% YoY (vs -27.3% in previous quarter and historical rate +46.4%)
- EBITDA margin 14.2% increased compared to 3.6% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 54.1x compared to historical level (75th percentile) of 91.1x
- EV/Sales multiple is 5.2x

------------------------------------------------

2026-11-11

#reports #MCFT

[MasterCraft Boat](https://eninvs.com/all.php?name=MCFT) (Recreational Vehicles) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204224)
(2026-05-07, Before Market Open):

- Revenue +136.9% YoY (vs +94.0% in previous quarter and historical rate +4.9%)
- EBITDA +200% YoY (vs -700.0% in previous quarter)
- EBITDA margin 7.8% increased compared to 6.2% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 7.5% of market cap
- EV/EBITDA multiple is 54.7x compared to historical level (75th percentile) of 28.5x
- EV/Sales multiple is 1x

------------------------------------------------

2026-11-11

#reports #MASS

[908 Devices Inc.](https://eninvs.com/all.php?name=MASS) (Medical Devices) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204218)
(2026-05-06, Before Market Open):

- Revenue +35.7% YoY (vs +23.1% in previous quarter and historical rate +12.5%)
- EBITDA margin -21.1% increased compared to -107.1% same period last year
- Net Debt decreased by $94 mln over the past reporting period (22.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/Sales multiple is 4.9x

------------------------------------------------

2026-11-11

#reports #KOPN

[Kopin Corporation](https://eninvs.com/all.php?name=KOPN) (Microdisplay manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204252)
(2026-05-12, Before Market Open):

- Revenue +151483.3% YoY (vs +127240.0% in previous quarter and historical rate +68.6%)
- EBITDA margin -1.9% increased compared to -50.0% same period last year
- Net Debt decreased by $1.9 bln since the start of the year (304.6% of market cap)
- FCF (LTM) -$5.3 bln (negative), 850.8% of market cap
- EV/Sales multiple is 1.6x

------------------------------------------------

2026-11-11

#reports #HBIO

[Harvard Bioscience](https://eninvs.com/all.php?name=HBIO) (Medical Instruments and Supplies) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204192)
(2026-04-30, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -8.2%)
- EBITDA margin -4.5% increased compared to -9.1% same period last year
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-11

#reports #CLFD

[Clearfield](https://eninvs.com/all.php?name=CLFD) (Communication Equipment) reported for 2026 q3
(2026-07-23, After Market Close):

- Revenue +116.7% YoY (vs -78.0% in previous quarter and historical rate -13.0%)
- EBITDA -75% YoY (vs -66.7% in previous quarter)
- EBITDA margin 2.6% decreased compared to 22.2% same period last year
- Net Debt decreased by $8 mln over the past reporting period (1.9% of market cap)
- EV/Sales multiple is 2.7x

------------------------------------------------

2026-11-11

#reports #BNGO

[Bionano Genomics](https://eninvs.com/all.php?name=BNGO) (Medicine analyzation platform provider ) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204207)
(2026-03-23, After Market Close):

- Revenue +14.3% YoY (vs +33.3% in previous quarter and historical rate +5.2%)
- EBITDA margin -50.0% increased compared to -57.1% same period last year
- Net Debt decreased by $2 mln over the past reporting period (12.9% of market cap)
- FCF (LTM) +$7.5 bln (positive), 48660.5% of market cap
- EV/Sales multiple is 0.4x

------------------------------------------------

2026-11-11

#reports #BGS

[B&G Foods](https://eninvs.com/all.php?name=BGS) ( Foods and household products manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204198)
(2026-05-12, After Market Close):

- Revenue +3.4% YoY (vs -19.4% in previous quarter and historical rate -11.6%)
- EBITDA -53.2% YoY (vs +4800.0% in previous quarter and historical rate +20.4%)
- EBITDA margin 6.3% decreased compared to 13.9% same period last year
- Net Debt increased by $45 mln over the past reporting period (20.8% of market cap)
- FCF (LTM) +$0 bln (positive), 4.2% of market cap
- EV/EBITDA multiple is 14.9x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 1.3x

------------------------------------------------

2026-11-11

#reports #AVNW

[Aviat Networks](https://eninvs.com/all.php?name=AVNW) (Communication Equipment) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204206)
(2026-05-04, After Market Close):

- Revenue +15.9% YoY (vs +286.0% in previous quarter and historical rate +28.4%)
- EBITDA margin 1.0% increased compared to -14.8% same period last year
- Net Debt increased by $9 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 77.8x
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-11-11

#reports #ATRO

[Astronics Corporation](https://eninvs.com/all.php?name=ATRO) (Aerospace electronics manufacturer) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue +28.9% YoY (vs +26.8% in previous quarter and historical rate +15.7%)
- EBITDA +92.9% YoY (vs +370.0% in previous quarter and historical rate +102.3%)
- EBITDA margin 19.9% increased compared to 13.3% same period last year
- Net Debt decreased by $26 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 19x compared to historical level (75th percentile) of 42x
- EV/Sales multiple is 3.3x

------------------------------------------------

2026-11-11

#reports #ASNS

[Actelis Networks, Inc.](https://eninvs.com/all.php?name=ASNS) (Communication Equipment) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204194)
(2026-05-14, After Market Close):

- Revenue -66.7% YoY (vs 0.0% in previous quarter and historical rate +3.3%)
- EBITDA margin -100.0% decreased compared to 0.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (157.6% of market cap)
- FCF (LTM) -$0 bln (negative), 157.6% of market cap
- EV/EBITDA multiple is 0.3x compared to historical level (75th percentile) of 1.5x
- EV/Sales multiple is -0.3x

------------------------------------------------

2026-11-11

#reports #AIRG

[Airgain](https://eninvs.com/all.php?name=AIRG) (Communication Equipment) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204196)
(2026-05-06, After Market Close):

- Revenue -6.3% YoY (vs -6.7% in previous quarter and historical rate -6.0%)
- Net Debt decreased by $1 mln over the past reporting period (1.8% of market cap)
- EV/Sales multiple is 1x

------------------------------------------------

2026-11-11

#reports #AHT

[Ashford Hospitality Trust](https://eninvs.com/all.php?name=AHT) (REIT — Hotel and Motel) reported for 2026 q3
(2026-02-25, After Market Close):

- Revenue -19.5% YoY (vs -9.6% in previous quarter and historical rate -9.3%)
- EBITDA +108.5% YoY (vs +164.7% in previous quarter and historical rate +31.9%)
- EBITDA margin 45.8% increased compared to 17.7% same period last year
- Net Debt decreased by $1.9 bln since the start of the year (13196.3% of market cap)
- FCF (LTM) -$1.9 bln (negative), 13107.0% of market cap
- EV/Sales multiple is -0.1x

------------------------------------------------

2026-11-11

#reports #ABUS

[Arbutus Biopharma Corporation](https://eninvs.com/all.php?name=ABUS) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204212)
(2026-05-13, Before Market Open):

- EBITDA margin -1000.0% increased compared to -1200.0% same period last year
- Net Debt decreased by $245 mln over the past reporting period (32.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 12.1% of market cap
- EV/Sales multiple is 32x

------------------------------------------------

2026-11-11

#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue -9.5% YoY (vs -5.0% in previous quarter and historical rate +15.0%)
- EBITDA margin -36.8% decreased compared to -33.3% same period last year
- Net Debt decreased by $26 mln over the past reporting period (68.4% of market cap)
- FCF (LTM) -$0 bln (negative), 60.5% of market cap
- EV/Sales multiple is 0.8x

------------------------------------------------

2026-11-11

#reports #TDG

[TransDigm](https://eninvs.com/all.php?name=TDG) (Aircraft component manufacturer) reported for 2026 q3
(2026-05-05, Before Market Open):

- Revenue +22.6% YoY (vs +22.5% in previous quarter and historical rate +19.2%)
- EBITDA +17.9% YoY (vs +18.3% in previous quarter and historical rate +21.4%)
- EBITDA margin 47.5% decreased compared to 49.4% same period last year
- Net Debt increased by $2.1 bln since the start of the year (3.1% of market cap)
- FCF (LTM) -$1.2 bln (negative), 1.8% of market cap
- EV/EBITDA multiple is 20x compared to historical level (75th percentile) of 25.8x
- EV/Sales multiple is 9.4x

------------------------------------------------

2026-11-11

#reports #SWKS

[Skyworks Solutions](https://eninvs.com/all.php?name=SWKS) (Semiconductor manufacturer) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue -4.9% YoY (vs -3.1% in previous quarter and historical rate -6.6%)
- EBITDA -19% YoY (vs -41.7% in previous quarter and historical rate -30.8%)
- EBITDA margin 12.6% decreased compared to 14.8% same period last year
- Net Debt increased by $169 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0.4 bln (positive), 5.6% of market cap
- EV/EBITDA multiple is 15.7x compared to historical level (75th percentile) of 16.1x
- EV/Sales multiple is 1.8x

------------------------------------------------

2026-11-11

#reports #SBH

[Sally Beauty](https://eninvs.com/all.php?name=SBH) (Professional cosmetics supplier ) reported for 2026 q3
(2026-05-11, Before Market Open):

- Revenue +0.6% YoY (vs +0.2% in previous quarter and historical rate +0.1%)
- EBITDA +13.5% YoY (vs +9.7% in previous quarter and historical rate +4.5%)
- EBITDA margin 12.4% increased compared to 11.0% same period last year
- Net Debt increased by $14 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 9.9% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 7.5x
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-11-11

#reports #RMBL

[RumbleON](https://eninvs.com/all.php?name=RMBL) (Auto and Truck Dealerships) reported for 2026 q3
(2025-08-11, After Market Close):

- Revenue -13.2% YoY (vs -1.0% in previous quarter and historical rate -9.5%)
- EBITDA -50% YoY (vs +17.6% in previous quarter and historical rate +48.3%)
- EBITDA margin 2.5% decreased compared to 4.3% same period last year
- Net Debt decreased by $430 mln over the past reporting period (296.9% of market cap)
- FCF (LTM) -$0.3 bln (negative), 174.7% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 636x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +15.5%

------------------------------------------------

2026-11-11

#reports #OVLY

[Oak Valley Bancorp](https://eninvs.com/all.php?name=OVLY) (Banks — Regional) reported for 2026 q3
(2025-01-17, After Market Close):

- Revenue +5.3% YoY (vs +5.6% in previous quarter and historical rate -0.1%)
- Net Income 0% YoY (vs 0.0% in previous quarter and historical rate -9.1%)
- Net Income margin 45.0% decreased compared to 47.4% same period last year
- P/E multiple is 9x compared to historical level (75th percentile) of 8.2x
- P/S multiple is 3.8x
- Price to book: 1.5x

------------------------------------------------

2026-11-11

#reports #NLST

[Netlist](https://eninvs.com/all.php?name=NLST) (Semiconductors) reported for 2026 q3
(2026-05-12, Before Market Open):

- Revenue +150% YoY (vs +161.9% in previous quarter and historical rate +96.3%)
- EBITDA margin 39.0% increased compared to -16.7% same period last year
- Net Debt increased by $27 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0.3 bln (positive), 12.8% of market cap
- EV/EBITDA multiple is 45.3x compared to historical level (75th percentile) of 1446x
- EV/Sales multiple is 5.5x

------------------------------------------------

2026-11-11

#reports #NCMI

[National CineMedia](https://eninvs.com/all.php?name=NCMI) (Advertising Agencies) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue -3.2% YoY (vs +11.5% in previous quarter and historical rate +29.0%)
- EBITDA -257.1% YoY (vs -400.0% in previous quarter and historical rate +26.6%)
- EBITDA margin -18.0% decreased compared to 11.1% same period last year
- Net Debt increased by $21 mln over the past reporting period (13.8% of market cap)
- FCF (LTM) +$0 bln (positive), 9.2% of market cap
- EV/EBITDA multiple is 65.7x compared to historical level (75th percentile) of 3.4x
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-11-11

#reports #MXCT

[MaxCyte, Inc.](https://eninvs.com/all.php?name=MXCT) (Medical Devices) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue +20% YoY (vs -16.7% in previous quarter and historical rate -19.8%)
- EBITDA margin -83.3% increased compared to -260.0% same period last year
- Net Debt increased by $88 mln over the past reporting period (72.9% of market cap)
- FCF (LTM) -$0 bln (negative), 5.0% of market cap
- EV/Sales multiple is 1.6x

------------------------------------------------

2026-11-11

#reports #KAI

[Kadant](https://eninvs.com/all.php?name=KAI) (Equipment manufacturer) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue +15.1% YoY (vs +22.7% in previous quarter and historical rate +8.8%)
- EBITDA +27.3% YoY (vs +29.4% in previous quarter and historical rate +14.5%)
- EBITDA margin 22.4% increased compared to 20.2% same period last year
- Net Debt decreased by $54 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 4.9% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 3.3x

Switch to company model in "Rising Stars" logic    *